Cite
HARVARD Citation
Schramm, A. et al. (n.d.). Next‐generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN‐amplified neuroblastoma. International journal of cancer. 132 (3), pp. E106-E115. [Online].